RSV vaccine product

Both the maternal (protecting infants) programme and the older-adult programme will be implemented with the vaccine Abrysvo® supplied by Pfizer.

View the summary of product characteristics (SmPC) for Abrysvo®.

Maternal programme information

The maternal programme will be implemented with Abrysvo® as a one-dose schedule. A single dose will be required in each pregnancy.

Older-adult programme information

The older-adult programme, including catch-up, will be implemented with Abrysvo® as a one-dose schedule.

Ordering

Abrysvo® will be available to order through vaccine holding centres from August 2024.

How it is supplied

The vaccine is supplied in single-dose packs and the presentation is a vial (containing active product) and a pre-filled syringe (containing sterile water solvent) for reconstitution.

Last updated: 11 December 2024
Was this page helpful?